Showing results (1441-1450 of 1,490) with videos related to

Sort By:
Pageof 149
Clinical and Translational Radiation Oncology|June 17, 2021
Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysisAmit Roy, Randall J Brenneman, Jacob Hogan, et al.
American Journal of Human Genetics|September 15, 2015
Genetic Defects in TAPT1 Disrupt Ciliogenesis and Cause a Complex Lethal OsteochondrodysplasiaSofie Symoens, Aileen M Barnes, Charlotte Gistelinck, et al.
Human Molecular Genetics|April 19, 2017
P4HA1 mutations cause a unique congenital disorder of connective tissue involving tendon, bone, muscle and the eyeYaqun Zou, Sandra Donkervoort, Antti M Salo, et al.
The EMBO Journal|November 19, 2017
The IKK-related kinase TBK1 activates mTORC1 directly in response to growth factors and innate immune agonistsCagri Bodur, Dubek Kazyken, Kezhen Huang, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 20, 2021
Guiding principles for determining work shift duration and addressing the effects of work shift duration on performance, safety, and health: guidance from the American Academy of Sleep Medicine and the Sleep Research SocietyIndira Gurubhagavatula, Laura K Barger, Christopher M Barnes, et al.
Biological Psychiatry Global Open Science|February 6, 2025
Depressive and Negative Symptoms in the Early and Established Stages of Schizophrenia: Integrating Structural Brain Alterations, Cognitive Performance, and Plasma Interleukin 6 LevelsFabiana Corsi-Zuelli, Gary Donohoe, Siân Lowri Griffiths, et al.
Translational Psychiatry|October 4, 2012
Adherence to a Mediterranean diet and Alzheimer's disease risk in an Australian populationS Gardener, Y Gu, S R Rainey-Smith, et al.
Nature Communications|July 7, 2016
MBTPS2 mutations cause defective regulated intramembrane proteolysis in X-linked osteogenesis imperfectaUschi Lindert, Wayne A Cabral, Surasawadee Ausavarat, et al.
British Journal of Cancer|November 16, 2024
Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancerRobert D Morgan, Xin Wang, Bethany M Barnes, et al.
Pageof 149